Skip to main content
. 2019 Apr 15;10(4):249–259. doi: 10.4239/wjd.v10.i4.249

Table 3.

Screening of diabetes-related complications in patients with diabetes mellitus

Screening for any diabetes-related complication, n (%)
Yes 553 (97.9)
No 12 (2.1)
Screening for cardiovascular disease
At least one time during the past year 376 (76.9)
Never 113 (23.1)
Eye screening
At least one time during the past year 295 (65.7)
Never 154 (34.3)
Number of eye screening, mean (SD) 1.20 (0.57)
Screening for nerve damage
At least one time during the past year 232 (53.8)
Never 199 (46.2)
Number of screening for nerve damage, mean ± SD 1.75 ± 1.01
Screening for kidney damage
At least one time during the past year 425 (82.5)
Never 90 (17.5)
Number of screening for kidney damage, mean ± SD 1.87 ± 1.02
Screening for foot examination
At least one time during the past year 297 (63.9)
Never 168 (36.1)
Number of screening for foot examination, mean ± SD 1.90 ± 1.08
Screening for blood lipid control
At least one time during the past year 496 (94.8)
Never 27 (5.2)
Number of screening for blood lipid control, mean ± SD 2.06 ± 1.04
Screening for blood pressure control n (%)
At least one time during the past year 286 (86.1)
Never 46 (13.9)
Number of screening for blood pressure control, mean ± SD 2.57 ± 1.17